Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aer Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Aer Therapeutics

Aer Therapeutics

Series A

Aer Therapeutics: Clinical-stage biopharma developing treatments for severe respiratory diseases.

HQ
Raleigh, NC, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Aer Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing novel inhaled therapies for severe respiratory diseases characterized by excess mucus and mucus plugs, such as COPD, cystic fibrosis, and asthma. The company's mission is to address significant unmet medical needs in the respiratory disease market by improving lung health through innovative treatments targeting muco-obstructive conditions.

Aer Therapeutics has made significant strides in the biopharmaceutical field, advancing its therapeutic solutions through rigorous clinical trials. By focusing on muco-obstructive lung diseases, the company aims to provide effective treatments that enhance the quality of life for patients suffering from chronic respiratory conditions.

Aer Therapeutics - Similar Companies

Aerami Therapeutics logo

Aerami Therapeutics

aerami.com

Aero Therapeutics logo

Aero Therapeutics

Aerwave Medical logo

Aerwave Medical

aerwavemed.com

Pulmatrix logo

Pulmatrix

pulmatrix.com

Aether Therapeutics logo

Aether Therapeutics

Respira Therapeutics logo

Respira Therapeutics

Theron Pharmaceuticals logo

Theron Pharmaceuticals

Airway Therapeutics logo

Airway Therapeutics

Respirics logo

Respirics

Kinaset Therapeutics logo

Kinaset Therapeutics

kinasettx.com

Orpro Therapeutics logo

Orpro Therapeutics

Axikin Pharmaceuticals logo

Axikin Pharmaceuticals

AerovectRx logo

AerovectRx

Metera Pharmaceuticals logo

Metera Pharmaceuticals

Aerin Medical logo

Aerin Medical

Aer Therapeutics - Quick Facts

Who are Aer Therapeutics' competitors?

Companies similar to Aer Therapeutics include Aerami Therapeutics, Aero Therapeutics, Aerwave Medical and Pulmatrix.

When was Aer Therapeutics founded?

Aer Therapeutics was founded in 2014.

Where is Aer Therapeutics' headquarters located?

Aer Therapeutics' headquarters is located in Raleigh, NC, US.

When was Aer Therapeutics' last funding round?

Aer Therapeutics' most recent funding round was for $36M (USD) in April 2023.

How much has Aer Therapeutics raised to-date?

As of Apr 13, 2023, Aer Therapeutics has raised a total of $36M (USD).

How many employees does Aer Therapeutics have?

Aer Therapeutics has 12 employees as of Feb 5, 2024.

Aer Therapeutics - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biopharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified